Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor

Clinical trial NCT04399343 · UNKNOWN

Trial details

NCT number: NCT04399343
Sponsor: Capital Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Central Nervous System Diseases

Start date: 2021-03-01
Primary completion: 2021-08-01
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.